Ardelyx Inc’s recent filing unveils that its President & CEO RAAB MICHAEL unloaded Company’s shares for reported $0.22 million on Mar 07 ’25. In the deal valued at $5.36 per share,41,668 shares were sold. As a result of this transaction, RAAB MICHAEL now holds 1,635,138 shares worth roughly $8.67 million.
Then, MOTT DAVID M bought 77,729 shares, generating $388,738 in total proceeds. Upon buying the shares at $5.00, the Director now owns 2,015,494 shares.
Before that, Williams Laura A sold 4,941 shares. Ardelyx Inc shares valued at $27,783 were divested by the Chief Medical Officer at a price of $5.62 per share. As a result of the transaction, Williams Laura A now holds 303,804 shares, worth roughly $1.61 million.
A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering ARDX and has decreased its forecast on November 11, 2024 with a “Neutral” recommendation from previously “Buy” rating. Piper Sandler revised its rating on July 02, 2024. It rated ARDX as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of ARDX
On Friday, Ardelyx Inc [NASDAQ:ARDX] saw its stock fall -0.38% to $5.30. Over the last five days, the stock has lost -1.12%. Ardelyx Inc shares have risen nearly 4.54% since the year began. Nevertheless, the stocks have fallen -44.73% over the past one year. While a 52-week high of $9.61 was reached on 02/19/25, a 52-week low of $4.32 was recorded on 02/24/25. SMA at 50 days reached $5.35, while 200 days put it at $5.79.
Levels Of Support And Resistance For ARDX Stock
The 24-hour chart illustrates a support level at 5.22, which if violated will result in even more drops to 5.13. On the upside, there is a resistance level at 5.43. A further resistance level may holdings at 5.56. The Relative Strength Index (RSI) on the 14-day chart is 47.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.89%. Stochastics %K at 30.22% indicates the stock is a holding.
The most recent change occurred on April 05, 2024 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $14 price target.
